Company Details
dr--reddys-laboratories
30,765
1,669,184
3254
drreddys.com
0
DR._2492461
In-progress

Dr. Reddy's Laboratories Company CyberSecurity Posture
drreddys.comEstablished in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ
Company Details
dr--reddys-laboratories
30,765
1,669,184
3254
drreddys.com
0
DR._2492461
In-progress
Between 750 and 799

DRL Global Score (TPRM)XXXX



No incidents recorded for Dr. Reddy's Laboratories in 2025.
No incidents recorded for Dr. Reddy's Laboratories in 2025.
No incidents recorded for Dr. Reddy's Laboratories in 2025.
DRL cyber incidents detection timeline including parent company and subsidiaries

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ


The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more th

HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketi
.png)
Dr. Reddy's Laboratories recorded a significant NSE block trade worth ₹32.40 crores involving 258904 shares at ₹1251.50 per share.
Hackers impersonated vendor in email scam, diverting ₹2.16 crore payment from dr Reddy's lab.
Dr Reddy's Laboratories successfully prevented a cyber fraud attempt involving vendor email impersonation. The hackers tried to redirect a...
Cybersecurity News: Dr Reddy's Laboratories lost Rs 2.16 crore to fraudsters who infiltrated an email thread and rerouted a payment to a...
Dr Reddy's Laboratories in India has lost ₹2.16 crore after cyber criminals allegedly hacked email exchanges with Group Pharmaceuticals and...
Dr. Reddy's Laboratories reportedly lost ₹2.16 crore in a major cyber fraud after scammers hacked into company email exchanges.
Dr. Reddy's Laboratories has reportedly lost Rs 2.16 crore after hackers impersonated an executive from a supplier firm and diverted funds...
Dr Reddy's Laboratories lost Rs 2.16 crore in a sophisticated cyber fraud scheme. Fraudsters used email spoofing to impersonate executives...
Bengaluru|November 9, 2025: Indian pharmaceutical major Dr. Reddy's Laboratories Ltd. has reportedly fallen victim to a sophisticated corporate cyber fraud,...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Dr. Reddy's Laboratories is http://www.drreddys.com.
According to Rankiteo, Dr. Reddy's Laboratories’s AI-generated cybersecurity score is 784, reflecting their Fair security posture.
According to Rankiteo, Dr. Reddy's Laboratories currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Dr. Reddy's Laboratories is not certified under SOC 2 Type 1.
According to Rankiteo, Dr. Reddy's Laboratories does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Dr. Reddy's Laboratories is not listed as GDPR compliant.
According to Rankiteo, Dr. Reddy's Laboratories does not currently maintain PCI DSS compliance.
According to Rankiteo, Dr. Reddy's Laboratories is not compliant with HIPAA regulations.
According to Rankiteo,Dr. Reddy's Laboratories is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Dr. Reddy's Laboratories operates primarily in the Pharmaceutical Manufacturing industry.
Dr. Reddy's Laboratories employs approximately 30,765 people worldwide.
Dr. Reddy's Laboratories presently has no subsidiaries across any sectors.
Dr. Reddy's Laboratories’s official LinkedIn profile has approximately 1,669,184 followers.
Dr. Reddy's Laboratories is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
No, Dr. Reddy's Laboratories does not have a profile on Crunchbase.
Yes, Dr. Reddy's Laboratories maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/dr--reddys-laboratories.
As of December 22, 2025, Rankiteo reports that Dr. Reddy's Laboratories has not experienced any cybersecurity incidents.
Dr. Reddy's Laboratories has an estimated 5,459 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Dr. Reddy's Laboratories has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.
Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.
A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.